Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Abiraterone acetate, a first-in-class CYP17 inhibitor, establishes a new treatment paradigm in castration-resistant prostate cancer.

× No keyword cloud information.

5 in total

Review 1. Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer.

Authors: Christopher Foley; Nicholas Mitsiades
Journal: Horm Cancer Date: 2016-01-04 Impact factor: 3.869

2. Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience.

Authors: R Petrioli; G Roviello; A I Fiaschi; L Laera; Salvatora T Miano; G De Rubertis; G Barbanti; V Bianco; S Brozzetti; E Francini
Journal: Med Oncol Date: 2015-01-31 Impact factor: 3.064

3. Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors.

Authors: Nicholas Mitsiades; Clifford C Sung; Nikolaus Schultz; Daniel C Danila; Bin He; Vijay Kumar Eedunuri; Martin Fleisher; Chris Sander; Charles L Sawyers; Howard I Scher
Journal: Cancer Res Date: 2012-09-12 Impact factor: 12.701

4. Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis.

Authors: Giandomenico Roviello; Silvia Paola Corona; Daniele Generali
Journal: Med Oncol Date: 2017-08-29 Impact factor: 3.064

5. P2Y1 agonist HIC in combination with androgen receptor inhibitor abiraterone acetate impairs cell growth of prostate cancer.

Authors: Hien Thi Thu Le; Akshaya Murugesan; Nuno R Candeias; Thiyagarajan Ramesh; Olli Yli-Harja; Meenakshisundaram Kandhavelu
Journal: Apoptosis Date: 2022-02-07 Impact factor: 4.677

5 in total